AuroBlog - Aurous Healthcare Clinical Trials blog

NOVEMBER 6, 2023

Ever feel like everything hurts after not getting enough sleep? A new study reveals a neurotransmitter involved in the pain that sleep deprivation causes, indicating a potential new target for treatment. In sleep-deprived mouse models, the neurotransmitter N-arachidonoyl dopamine (NADA), an endocannabinoid, was reduced in one brain region linked to sensory processing and arousal.

Clinical Trials 246

Clinical Trials Clinical Trials Trials 246

Pharmaceutical Technology

NOVEMBER 6, 2023

GlobalData uncovers the leading innovators in rAAV production technology for the pharmaceutical industry.

Gene Therapy 223

Gene Therapy Production Gene 223

AuroBlog - Aurous Healthcare Clinical Trials blog

NOVEMBER 6, 2023

India’s smart doctor promoters are seeking help of professional healthcare management companies to introduce best healthcare management practices in their establishments, said Raj Sehgal associate director, TR Lifesciences. This is because these clinics encounter challenges even as there are growth prospects.

Doctor 185

Doctor Doctors Clinical Trials Clinical Trials 185

Bio Pharma Dive

NOVEMBER 6, 2023

Shares in the biotech jumped higher Monday on positive results for the company's drug barzolvolimab in two chronic itching conditions.

Drugs 173

Drugs 173

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Medicine

Pharmaceutical Technology

NOVEMBER 6, 2023

Krazati received conditional marketing authorisation as a second-line treatment of KRAS-G12C mutated locally advanced or metastatic NSCLC.

Marketing 162

Marketing 162

Bio Pharma Dive

NOVEMBER 6, 2023

A deal with Orum Therapeutics gives the large pharma access to an experimental blood and bone marrow cancer drug that's ready to enter clinical testing.

Drugs 162

Drugs 162

Pharmaceutical Technology

NOVEMBER 6, 2023

At AAO 2023, results were presented from the Phase III GALE trial, evaluating Apellis Pharmaceuticals’s Syfovre to treat geographic atrophy (GA).

Trials 147

Trials 147

Bio Pharma Dive

NOVEMBER 6, 2023

Developing holistic treatment approaches that address patient needs today and in the future.

Development 147

Development 147

Pharma Times

NOVEMBER 6, 2023

The image helps researchers understand how heart muscles operate in disease - News - PharmaTimes

Research 135

Research 135

Bio Pharma Dive

NOVEMBER 6, 2023

Industry-leading cold storage manufacturers are engineering new solutions that can reliably meet performance benchmarks while consuming far less energy than yesterday’s ULT and laboratory-grade freezers.

Engineer 147

Engineer Manufacturing 147

Advertisement

Clinical Supply

Pharmaceutical Technology

NOVEMBER 6, 2023

GlobalData uncovers the leading innovators in synthetic COVID vaccines for the pharmaceutical industry.

Vaccine 130

Vaccine Vaccination 130

pharmaphorum

NOVEMBER 6, 2023

How over-investment is killing digital health companies Mike.

128

128

Pharmaceutical Technology

NOVEMBER 6, 2023

Orum’s drug has an FDA clearance for the therapy to enter Phase I testing in AML and myelodysplastic syndromes.

Drugs 130

Drugs 130

Fierce Pharma

NOVEMBER 6, 2023

History may repeat for Vertex Pharmaceuticals in the U.K., where a new decision by the country’s cost-effectiveness gatekeeper threatens to spark another dispute over the cost of lifesaving cystic | Last week, the U.K.'s National Institute for Health and Care Excellence unveiled draft guidance that acknowledged the effectiveness of Vertex’s cystic fibrosis drugs Trikafta, Symkevi and Orkambi.

Medicine 124

Medicine Drugs 124

Advertisement

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

Clinical Trials

Pharmaceutical Technology

NOVEMBER 6, 2023

GlobalData uncovers the leading innovators in pancreatic cell transplantation for the pharmaceutical industry.

Gene Therapy 130

Gene Therapy Gene 130

Fierce Pharma

NOVEMBER 6, 2023

As Vertex preps for exa-cel launch, exec touts 'very large' opportunity but tempers early expectations zbecker Mon, 11/06/2023 - 20:59

122

122

Pharmaceutical Technology

NOVEMBER 6, 2023

GlobalData uncovers the leading innovators in influenza vaccine vectors for the pharmaceutical industry.

Vaccine 130

Vaccine Vaccination 130

pharmaphorum

NOVEMBER 6, 2023

Anthropy23, part one: The future of AI, the future of Britain Mike.

122

122

Advertisement

Clinical Supply

Pharmaceutical Technology

NOVEMBER 6, 2023

Trading under the ticker symbol ‘KRRO’, the new business’s initial focus is advancing an Alpha-1 antitrypsin deficiency candidate into trials.

Trials 130

Trials 130

pharmaphorum

NOVEMBER 6, 2023

Drug combos from AZ, Boehringer show promise in CKD Phil.

Drugs 121

Drugs 121

Pharmaceutical Technology

NOVEMBER 6, 2023

GlobalData uncovers the leading innovators in intracellular receptor modulators for the pharmaceutical industry.

130

130

Fierce Pharma

NOVEMBER 6, 2023

At the start of its first-ever conference call to present its quarterly numbers, Krystal Biotech CEO Krish Krishnan was quick to point out that the company’s positive earnings for the third quarter | Krystal Biotech's launch of Vyjuvek, the world's first topical gene therapy, has been so promising that analysts with Evercore ISI increased their 2024 sales projection to $273 million.

Gene Therapy 119

Gene Therapy Sales Gene FDA Approval 119

Advertisement

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

Clinical Trials

Pharmaceutical Technology

NOVEMBER 6, 2023

GlobalData uncovers the leading innovators in personalized cancer vaccines for the pharmaceutical industry.

Vaccine 130

Vaccine Vaccination Medicine 130

pharmaphorum

NOVEMBER 6, 2023

UK patient data project reaches one million volunteers Phil.

119

119

Pharmaceutical Technology

NOVEMBER 6, 2023

GlobalData uncovers the leading innovators in microencapsulated peptide vaccines for the pharmaceutical industry.

Vaccine 130

Vaccine Vaccination 130

Fierce Pharma

NOVEMBER 6, 2023

After this summer’s FDA approval of Iveric Bio’s Izervay—the drug at the center of the $5.9 billion buyout by Japanese pharma Astellas—the battle for the geographic atrophy (GA) crown is on in the | After this summer’s approval of Iveric Bio’s Izervay—the drug at the center of the $5.9 billion buyout by Japanese pharma Astellas—the battle for the geographic atrophy crown is on in the U.S.

FDA Approval 115

FDA Approval Drugs 115

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Clinical Research

Pharmaceutical Technology

NOVEMBER 6, 2023

GlobalData uncovers the leading innovators in oncolytic viruses for the pharmaceutical industry.

130

130

Fierce Pharma

NOVEMBER 6, 2023

Following suit with other companies that produce COVID-19 vaccines, BioNTech has discovered demand for its Pfizer-partnered, omicron-adapted shot has not met expectations this fall and has had to a | BioNTech has slashed its estimate of 2023 revenue by 20%, now expecting it to reach 4 billion euros ($4.3 billion) versus its previous estimate of 5 billion euros ($5.4 billion).

Sales 114

Sales Vaccine Vaccination 114

Pharmaceutical Technology

NOVEMBER 6, 2023

GlobalData uncovers the leading innovators in miRNA modulation for the pharmaceutical industry.

130

130

pharmaphorum

NOVEMBER 6, 2023

Bayer doubles down on Factor XIa with new phase 3 trial Phil.

Trials 113

Trials 113

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials